u/ravi_sandvik

the injection-site soreness passes. i promise. not medical advice.

This is the "correlation is mechanism" thing again. You changed three variables at once.

the tier 3 pathway is the only free route, it is slow

CagriSema is a fixed combo in trials, not user-mixed

Went up because the scale stalled, not because I needed to. Do not be me. The stall broke on its own at the higher dose.

Not to be pedantic but ferritin and ApoB are being used interchangeably and they are not interchangeable in real life.

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

Which country? Half the answers in this thread only apply in the Netherlands.

baseline is the most important ferritin measurement, you cannot collect it later

testing the vendor claim versus testing your actual vial are two different posts

Retitled to remove editorialising.

Yes, exactly this, and it is the bit that took me 57 weeks to accept.

Strongly agree. The supply impact would be huge.

template required: vendor / product / batch / service / method / result

the 2.4mg dose is not the target, it is just what the pen goes up to

Did you test the vial you received or are we going off the vendor COA?

Kept a public log for 44 weeks. The comments are what kept it going, honestly. Accountability from strangers works.

Did anything else change in the same window? Sleep, protein, steps, anything?

multiple batches from SWB show a spread, that is the data

This is correct. ATTAIN data is phase 16.